GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:16964310
Citation |
Toro, A and Grunebaum, E (2006) TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J. Clin. Invest. 116:2717-26 |
---|---|
Abstract |
Defects in purine nucleoside phosphorylase (PNP) enzyme activity result in abnormal nucleoside homeostasis, severe T cell immunodeficiency, neurological dysfunction, and early death. Protein transduction domain (PTD) can transfer molecules into cells and may help restore PNP activity in cases of PNP deficiency. However, long-term use of PTD to replace enzymes in animal models or patients has not previously been described. We fused human PNP to the HIV-TAT PTD and found that the fusion with TAT changed the retention and distribution of PNP in PNP-deficient mice. TAT induced rapid intracellular delivery of PNP into tissues, including the brain, prevented urinary excretion of PNP, and protected PNP from neutralizing antibodies, resulting in significant extension of the enzyme's biological activity in vivo. Frequent TAT-PNP injections in PNP-deficient mice corrected the metabolic disorder and immune defects with no apparent toxicity. TAT-PNP remained effective over 24 weeks of treatment, resulting in continued improvement in immune function and extended survival. Our data demonstrate that TAT changes the properties of PNP in vivo and that long-term intracellular delivery of PNP by TAT corrects PNP deficiency in mice. We provide evidence to promote further use of PTD to treat diseases that require repeated intracellular enzyme or protein delivery. |
Links |
PubMed PMC1560347 Online version:10.1172/JCI25052 |
Keywords |
Animals; Body Weight; Brain/enzymology; CD4-Positive T-Lymphocytes/cytology; CD4-Positive T-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/cytology; CD8-Positive T-Lymphocytes/immunology; Cell Count; Gene Products, tat/genetics; Humans; Liver/enzymology; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments/genetics; Purine-Nucleoside Phosphorylase/deficiency; Purine-Nucleoside Phosphorylase/genetics; Purine-Nucleoside Phosphorylase/metabolism; Purine-Pyrimidine Metabolism, Inborn Errors/enzymology; Purine-Pyrimidine Metabolism, Inborn Errors/genetics; Recombinant Fusion Proteins/administration & dosage; Recombinant Fusion Proteins/genetics; Recombinant Fusion Proteins/metabolism; Spleen/enzymology; Survival Analysis; Thymus Gland/cytology; Thymus Gland/enzymology; Transfection/methods; Treatment Outcome; Uric Acid/metabolism; Uric Acid/urine; tat Gene Products, Human Immunodeficiency Virus |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.